Search for more clinical trials
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women With Advanced Breast Cancer
Conditions
Advanced Breast Cancer
Conditions: official terms
Breast Neoplasms
Conditions: Keywords
Premenopausal Women with Advanced Breast Cancer
Study Type
Observational
Study Phase
N/A
Study Design
Observational Model: Case Control, Time Perspective: Prospective
Intervention
Name: GnRh Analogue and Aromatase Inhibitor
Type: Other
Overall Status
Recruiting
Summary
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women with Advanced Breast Cancer A Prospective Trial.
Detailed Description
The Combination of GnRh Analogue and Aromatase Inhibitor in Receptor Positive Premenopausal Women with Advanced Breast Cancer A Prospective Trial.
Criteria for eligibility
Healthy Volunteers: No
Maximum Age: 85 Years
Minimum Age: 45 Years
Gender: Female
Criteria: Inclusion Criteria:
- Receptor Positive Premenopausal Women with Advanced Breast Cancer.
Exclusion Criteria:
- Any woman other than diagnosis of Receptor Positive Premenopausal with Advanced Breast Cancer.
- Receptor Positive Premenopausal Women with Advanced Breast Cancer.
Exclusion Criteria:
- Any woman other than diagnosis of Receptor Positive Premenopausal with Advanced Breast Cancer.
Location
Kfsh & Rc
Riyadh, Saudi Arabia
Status: Recruiting
Start Date
January 2009
Sponsors
King Faisal Specialist Hospital & Research Center
Source
King Faisal Specialist Hospital & Research Center
Record processing date
ClinicalTrials.gov processed this data on July 28, 2015
ClinicalTrials.gov page